Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
Author(s) -
Sudipa Saha Roy,
Ratna K. Vadlamudi
Publication year - 2011
Publication title -
international journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 15
eISSN - 2090-3170
pISSN - 2090-3189
DOI - 10.1155/2012/654698
Subject(s) - estrogen receptor , breast cancer , metastasis , cancer research , medicine , signal transduction , cancer , estrogen receptor alpha , estrogen , breast cancer metastasis , biology , cancer metastasis , microbiology and biotechnology
Metastatic breast cancer is a life-threatening stage of cancer and is the leading cause of death in advanced breast cancer patients. Estrogen signaling and the estrogen receptor (ER) are implicated in breast cancer progression, and the majority of the human breast cancers start out as estrogen dependent. Accumulating evidence suggests that ER signaling is complex, involving coregulatory proteins and extranuclear actions. ER-coregualtory proteins are tightly regulated under normal conditions with miss expression primarily reported in cancer. Deregulation of ER coregualtors or ER extranuclear signaling has potential to promote metastasis in ER-positive breast cancer cells. This review summarizes the emerging role of ER signaling in promoting metastasis of breast cancer cells, discusses the molecular mechanisms by which ER signaling contributes to metastasis, and explores possible therapeutic targets to block ER-driven metastasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom